Anxiety Syndrome

  • Randolph B. Schiffer
  • Robert F. Klein
  • Roger C. Sider

Abstract

Panic Disorders with and without Agoraphobia. The essential features of these disorders are recurrent panic attacks, i.e., discrete periods of intense fear or discomfort. The panic attacks usually last minutes or, more rarely, hours. They are accompanied by associated somatic symptoms, such as dyspnea, palpitations, diaphoresis, tingling, and others.

Keywords

Anxiety Disorder Panic Disorder Panic Attack Mitral Valve Prolapse Anxious Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackner, B., Cooper, J. E., Gray, C. H., and Kelly, M. Acute porphyria: A neuropsychiatric and biochemical study. J. Psychosom. Res., 1962, 6, 1–24.PubMedCrossRefGoogle Scholar
  2. Aronson, T. A., and Craig, T. J. Cocaine precipitation of panic disorders. Am. J. Psychiatry, 1986, 143, 643–645.PubMedGoogle Scholar
  3. Bowen, R. C., Orchard, R. C., Keegan, D. L., and D’Arcy, C. Mitral valve prolapse and psychiatric disorders. Psychosomatics, 1985, 26, 926–932.PubMedCrossRefGoogle Scholar
  4. Bravo, E. L., Tarazi, R. C., Gifford, R. W., and Stewart, B. H. Circulatory and urinary catecholamines in pheochromocytoma: Diagnosis and pathophysiologic implications. N. Engl. J. Med. 1979, 301, 682–686.PubMedCrossRefGoogle Scholar
  5. Breier, A., Chamey, D. S., and Heninger, G. R. Major depression in patients with agoraphobia and panic disorder. Arch. Gen. Psychiatry, 1984, 41, 1129–1135.PubMedCrossRefGoogle Scholar
  6. Brodsky, L., Zuniga, J. S., and Casenas, E. R. Refractory anxiety: A masked epileptiform disorder? Psychiatr. M. Univ. Ottawa, 1983, 8, 42–45.Google Scholar
  7. Carlson, R. J. Longitudinal observations of two cases of organic anxiety syndrome. Psychosomatics, 1986, 27, 529–531.PubMedCrossRefGoogle Scholar
  8. Chopra, I. J., and Solomon, D. H. Pathogenesis of hyperthyroidism. Annu. Rev. Med., 1983, 34, 267–281.PubMedCrossRefGoogle Scholar
  9. Coyle, P. K., and Sterman, A. B. Focal neurologic symptoms in panic attacks. Am. J. Psychiatry, 1986, 143, 648–649.PubMedGoogle Scholar
  10. Crooks, J., Murray, I. P. C., and Wayne, E. J. Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Q. J. M., 1959, 28, 211–234.Google Scholar
  11. Denko, J. D., and Kaelbling, R. The psychiatric aspects of hypoparathyroidism. Acta Psychiatr. Scand., 1962, 38 (Suppl. 164), 1–70.Google Scholar
  12. Diagnostic and Statistical Manual of Mental Disorders,3d ed., Rev. Washington, DC: American Psychiatric Association, 1987.Google Scholar
  13. Dietch, J. T. Diagnosis of organic anxiety disorders. Psychosomatics, 1981, 22, 661–669.PubMedGoogle Scholar
  14. Eales, L. Porphyria and the dangerous life-threatening drugs. S. Afr. Med. J., 1979, 56, 914–917.PubMedGoogle Scholar
  15. Edlund, M. J., Swann, A. C., and Clothier, J. Patients with panic attacks and abnormal EEG results. Am. J. Psychiatry, 1987, 144, 508–509.PubMedGoogle Scholar
  16. Goldfrank, L., and Starke, C. L. Metabolic acidosis in the alcoholic. Hosp. Physician, 1979, 14, 34–37.Google Scholar
  17. Gorman, J. M., Shear, M. K., Devereux, R. B., King, D. L., and Klein, D. F. Prevalence of mitral valve prolapse in panic disorder: Effect of echocardiographic criteria. Psychosom. Med., 1986, 48, 167–171.PubMedGoogle Scholar
  18. Greden, J. F. Anxiety or caffeinism: A diagnostic dilemma. Am. J. Psychiatry, 1974, 131, 1089 1092.Google Scholar
  19. Greden, J. F., Fontaine, P., Lubetsky, M., and Chamberlin, K. Anxiety and depression associated with caffeinism among psychiatric inpatients. Am. J. Psychiatry, 1978, 135, 963–966.PubMedGoogle Scholar
  20. Hamburger, J. I. The various presentations of thyroiditis. Diagnostic considerations. Ann. Intern.Med., 1986, 104, 219–224.PubMedCrossRefGoogle Scholar
  21. Heinik, J. Hyperthyroidism and the organic anxiety syndrome. Am. J. Psychiatry,1986, 143 1497–1498 (letter).Google Scholar
  22. Hoehn-Saric, R. Neurotransmitters in anxiety. Arch. Gen. Psychiatry, 1982, 39, 735–742. Hoffman, W. H., Chodoroff, G., and Piggott, L. R. Haloperidol and thyroid storm. Am. J. Psychiatry, 1978, 135, 484–486.Google Scholar
  23. Hurley, J. R. Thyroid disease in the elderly. Med. Clin. North Am., 1983, 67, 497–516. Jefferson, J. W., and Marshall, J. R. Neuropsychiatric Features of Medical Disorders. New York: Plenum Press, 1981, p. 4.Google Scholar
  24. Kaplan, M. M., and Utiger, R. D. Diagnosis of hyperthyroidism. Clin. Endocrinol. Metab., 1978, 7, 97–113.PubMedCrossRefGoogle Scholar
  25. Kathol, R. G., Turner, R., and Delahunt, J. Depression and anxiety associated with hyperthyroidism: Response to antithÿroid therapy. Psychosomatics, 1986, 27, 501–505.PubMedCrossRefGoogle Scholar
  26. Leckman, J. F., Merikangas, K. R., Pauls, D. L., Prusoff, B. A., and Weismann, M. M. Anxiety disorders and depression: Contradictions between family study data and DSM III conventions. Am. J. Psychiatry, 1983, 140, 880–882.PubMedGoogle Scholar
  27. Levine, R. Hypoglycemia. JAMA, 1974, 230, 462–463.PubMedCrossRefGoogle Scholar
  28. Liberthson, R., Sheehan, D. V., King, M. E., and Weyman, A. E. The prevalance of mitral valveGoogle Scholar
  29. prolapse in patients with panic disorders. Am. J. Psychiatry, 1986, 143, 511–515.Google Scholar
  30. Maturzas, W., Al-Sadir, J., Uhlenhuth, E. H., and Glass, R. M. Mitral valve prolapse and thyroidGoogle Scholar
  31. abnormalities in patients with panic attacks. Am. J. Psychiatry, 1987, 144, 493–496.Google Scholar
  32. May, P. R. A., and Ebaugh, F. G. Pathological intoxication, alcoholic hallucinosis, and otherGoogle Scholar
  33. reactions to alcohol: A clinical study. Q. J. Stud. Alcohol, 1953, 14, 200–227.Google Scholar
  34. Mazza, D. L., Martin, D., Spacavento, L., Jacobsen, J., and Gibbs, H.Prevalence of anxietyGoogle Scholar
  35. disorders in patients with mitral valve prolapse. Am. J. Psychiatry,1986, 143 349–352. Medical Letter. Drugs that cause psychiatric symptoms. Med. Lett. Drugs Ther.,1986, 28 Google Scholar
  36. Mental Disorders: Glossary and Guide to Their Classification in Accordance with the Ninth Revision of the International Classification of Diseases. Geneva: World Health Organization, 1978.Google Scholar
  37. Miles, W. R. The comparative concentration of alcohol in human blood and urine at intervals after ingestion. J. Pharmacol. Exp. Ther., 1922, 20, 265.Google Scholar
  38. New England Journal of Medicine. Table of normal reference laboratory values. N. Engl. J. Med., 1986, 314, 39–49.CrossRefGoogle Scholar
  39. Nishimura, R. A., McGoon, M. D., Shub, C., Miller, F. A., Ilstrup, D. M., and Tajik, A. J.Google Scholar
  40. Echocardiographically documented mitral-valve prolapse: Long-term follow-up of 237 patients. N. Engl. J. Med., 1985, 313, 1305–1309.CrossRefGoogle Scholar
  41. Pathak, M. A., and West, J. D. Porphyrias: Office procedures and laboratory tests for diagnosisGoogle Scholar
  42. of porphyrin abnormalities. Acta Derma. Venereol. (Stockh.), 1982, 100 (Suppl.), 91–105. Rosenman, R.H. The impact of anxiety on the cardiovascular system. Psychosomatics,1985, 26 Google Scholar
  43. Suppl. 11), 6–15.Google Scholar
  44. Savage, D. D., Garrison, R. J., Devereux, R. B., Castelli, W. P., Anderson, S. J., Levy, D., McNamara, P. M., Stokes, K., Kannel, W. B., and Feinleib, M. Mitral valve prolapse in the general population. I. Epidemiologic features: The Framingham Study. Am. Heart J., 1983, 106, 571–576.PubMedCrossRefGoogle Scholar
  45. Schuckit, M. A. Anxiety related to medical disease. J. Clin. Psychiatry, 1983, 44, 31–36. Shader, R. I. Panic disorders: Epidemiologic and family studies. Psychosomatics, 1984, 25 (Suppl. 10), 10–15.CrossRefGoogle Scholar
  46. Shader, R. I., Goodman, M., and Geyer, J. Panic disorders: Current perspectives. J. Clin. Psychopharmacol., 1982, 2 (Suppl. 6), 25–105.Google Scholar
  47. Starkman, M. N., Zelnik, T. C., Nesse, R. M., and Cameron, O. G. Anxiety in patients with pheochromocytomas. Arch. Intern. Med., 1985, 145, 248–252.PubMedCrossRefGoogle Scholar
  48. Stein, M. B. Panic disorder and medical illness. Psychosomatics, 1986, 27, 833–838. Szmuilowicz, J., and Flannery, J. G. Mitral valve prolapse syndrome and psychological disturbance. Psychosomatics, 1980, 21, 419–421.Google Scholar
  49. Tishler, P. V., Woodward, B., O’Connor, J., Holbrook, D. A., Seidman, L. J., Hallett, M., and Knighton, D. J. High prevalence of intermittent acute porphyria in a psychiatric patient population. Am. J. Psychiatry, 1985, 142, 1430–1436.PubMedGoogle Scholar
  50. Tschudy, D. P., Valsamis, M., and Magnussen, C. R. Acute intermittent porphyria: Clinical and selected research aspects. Ann. Intern. Med., 1975, 183, 851–864.CrossRefGoogle Scholar
  51. Weiner, M. F. Haloperidol, hyperthyroidism, and sudden death. Am. J. Psychiatry, 1979, 136, 717–718.PubMedGoogle Scholar
  52. Weissman, M. M., Myers, J. K., and Harding, P. S. Psychiatric disorders in a U.S. urban community, 1975–1976. Am. J. Psychiatry, 1978, 135, 459–462.Google Scholar
  53. Williams, L. C., Turney, J. H., and Parsons, V. Beta blocker withdrawal syndrome. Lancet, 1979, 1, 94–95 (letter).Google Scholar
  54. Wilson, W. H., and Jefferson, J. W. Thyroid disease, behavior, and psychopharmacology. Psychosomatics, 1985, 26, 481–492.PubMedCrossRefGoogle Scholar
  55. Witschy, J. K., and Redmond, F. C. Extrapyramidal reaction to fluphenazine potentiated by thyrotoxicosis. Am. J. Psychiatry, 1981, 138, 246–247.PubMedGoogle Scholar
  56. Wynne, J. Mitral valve prolapse. N. Engl. J. Med.,1986, 314 577–578 (letter).Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Randolph B. Schiffer
    • 1
  • Robert F. Klein
    • 1
  • Roger C. Sider
    • 2
  1. 1.The University of Rochester School of Medicine and DentistryRochesterUSA
  2. 2.Pine Rest Christian HospitalGrand RapidsUSA

Personalised recommendations